Financhill
Back

Lucid Diagnostics Stock Predictions

Lucid Diagnostics Stock Forecast

  • Is Lucid Diagnostics Stock Undervalued?
    The current Lucid Diagnostics [LUCD] share price is $1.39. The Score for LUCD is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
  • LUCD is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Will Lucid Diagnostics Stock Go Up Next Year?

Data Unavailable

Lucid Diagnostics Stock Rating

Data Unavailable

Lucid Diagnostics Stock Price History

Is LUCD stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and LUCD is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Health Care Equipment & Supplies
Sector:
Health Care
Type:
stock
Website:
luciddx.com

52-Week Data

52-Week High:
1.63
52-Week Low:
0.63

Prediction Charts

Market Cap:
82.5M
Price in USD:
1.39
Volume:
1.2M
Beta:
1.32

Technical Analysis

SMA50:
1.10
SMA100:
1.00
SMA200:
0.91
52-Wk Change:
24.11%

Stock Predictions

  • Is Lucid Diagnostics stock public?
    Yes, Lucid Diagnostics is a publicly traded company.
  • What is the Lucid Diagnostics stock quote today?
    The Lucid Diagnostics stock price is 1.39 USD today.
  • How to buy Lucid Diagnostics stock online?
    You can buy Lucid Diagnostics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Feb-21 1.52 1.46 1.59 1.44
Feb-25 1.37 1.42 1.47 1.34
Feb-26 1.45 1.43 1.45 1.36
Feb-27 1.42 1.50 1.55 1.40
Feb-28 1.51 1.48 1.55 1.44
Mar-3 1.48 1.34 1.53 1.34
Mar-4 1.23 1.30 1.32 1.20
Mar-5 1.44 1.35 1.44 1.31
Mar-6 1.45 1.39 1.47 1.27
Mar-7 1.41 1.39 1.41 1.36
Mar-11 1.21 1.22 1.24 1.18
Mar-12 1.24 1.32 1.34 1.20
Mar-13 1.32 1.28 1.35 1.24
Mar-14 1.31 1.39 1.46 1.29

Lucid Diagnostics Earnings

Data Unavailable

Lucid Diagnostics Forecast Revenue Growth

Data Unavailable

  • Analysts estimate an earnings increase this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.24 per share, and an increase next year of $0.16 per share.

* Lucid Diagnostics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.